📄7 trials. 553 patients. Zero significant differences.
Our new RCT-only meta-analysis: DOACs match warfarin for left ventricular thrombus — same thrombus resolution & bleeding, simpler dosing. Paper from #CardioCoimbra
📄 @HeartLungCirc
🔗 https://t.co/CYUTh5y557
Proud to share our @KCJ article on early in-hospital initiation of SGLT2 inhibitors in acute HF.
In 8 RCTs/3,596 patients, early SGLT2i reduced all-cause mortality without excess safety events.
Honoured to see it discussed in an accompanying editorial.
https://t.co/kqnIbFfrtb
🚨 Hot off the press from #CoimbraCardio! 🚨
Even though the latest ESC guidelines have downgraded P2Y12 inhibitors STEMI pretreatment, could UFH be the game-changer in the pre-cath lab setting? 🩺💉 Let’s dive into the potential benefits! 🔍 #Cardiology#cardiotwitter🚨
A 🧵
Último dia #cpc2024, não podia faltar o clássico Cardioquizz do CJC!
Com 16 equipas inscritas, foi uma competição renhida, mas a equipa "Godlines" saiu em vitória, ganhando inscrição para ESC!
@gnfcosta